Literature DB >> 17255258

Decreased NKG2D expression on CD8+ T cell is involved in immune evasion in patients with gastric cancer.

Tomohiro Osaki1, Hiroaki Saito, Toshiaki Yoshikawa, Sachiko Matsumoto, Shigeru Tatebe, Shunichi Tsujitani, Masahide Ikeguchi.   

Abstract

PURPOSE: Some studies suggest that the immunoreceptor NKG2D expression on CD8(+) T cells is down-regulated and this reduction may be involved in immune evasion in cancer patients. The present study was designed to investigate NKG2D expression on CD8(+) T lymphocytes and its relationship to immune evasion in gastric cancer patients. EXPERIMENTAL
DESIGN: NKG2D expression on both circulating and tumor-infiltrating CD8(+) T cells was evaluated by multicolor flow cytometry. Soluble MHC class I chain-related gene A (MICA) in the sera was quantitated by ELISA. Transwell experiments were carried out to determine the effect of cancer cells on NKG2D expression.
RESULTS: NKG2D expression on circulating CD8(+) T cells was down-regulated and significantly correlated with IFN-gamma production in gastric cancer patients (r = 0.68; P = 0.007). NKG2D expression was closely related to undifferentiated cancer (P = 0.021) as was the depth of invasion (P = 0.012). There was no difference in soluble MICA between gastric cancer patients and normal controls. NKG2D expression on CD8(+) T cells was remarkably reduced in the tissue of gastric cancer compared with peripheral blood (P = 0.046). Complete removal of tumor by surgery restored NKG2D expression on CD8(+) T cells (P = 0.0049). Transwell experiments showed that this down-regulation was induced by direct contact between cancer cells and CD8(+) T cells and that soluble factors did not affect the NKG2D expression. This phenomenon was blocked by the addition of anti-MICA antibodies.
CONCLUSIONS: Decreased NKG2D expression may be one of the key mechanisms responsible for immune evasion by tumors in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255258     DOI: 10.1158/1078-0432.CCR-06-1454

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  16 in total

Review 1.  Dual roles for immunity in gastrointestinal cancers.

Authors:  Cristina Ferrone; Glenn Dranoff
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

2.  An increased number of PD-1+ and Tim-3+ CD8+ T cells is involved in immune evasion in gastric cancer.

Authors:  Shuichi Takano; Hiroaki Saito; Masahide Ikeguchi
Journal:  Surg Today       Date:  2016-01-22       Impact factor: 2.549

3.  Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer.

Authors:  Hiroaki Saito; Tomohiro Osaki; Masahide Ikeguchi
Journal:  Gastric Cancer       Date:  2011-05-31       Impact factor: 7.370

4.  Regulation of NKG2D+CD8+ T-cell-mediated antitumor immune surveillance: Identification of a novel CD28 activation-mediated, STAT3 phosphorylation-dependent mechanism.

Authors:  Jiemiao Hu; Izhar S Batth; Xueqing Xia; Shulin Li
Journal:  Oncoimmunology       Date:  2016-11-01       Impact factor: 8.110

5.  Decreased number and reduced NKG2D expression of Vδ1 γδ T cells are involved in the impaired function of Vδ1 γδ T cells in the tissue of gastric cancer.

Authors:  Hirohiko Kuroda; Hiroaki Saito; Masahide Ikeguchi
Journal:  Gastric Cancer       Date:  2012-01-18       Impact factor: 7.370

6.  MICA polymorphisms and decreased expression of the MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis susceptibility.

Authors:  Arnoldo Aquino-Galvez; Martha Pérez-Rodríguez; Angel Camarena; Ramces Falfan-Valencia; Víctor Ruiz; Martha Montaño; Lourdes Barrera; Isabel Sada-Ovalle; Remedios Ramírez; Julio Granados; Annie Pardo; Moisés Selman
Journal:  Hum Genet       Date:  2009-04-12       Impact factor: 4.132

7.  Implication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer.

Authors:  Congqi Dai; Fengjuan Lin; Ruixuan Geng; Xiaoxiao Ge; Wenbo Tang; Jinjia Chang; Zheng Wu; Xinyang Liu; Ying Lin; Zhe Zhang; Jin Li
Journal:  Oncotarget       Date:  2016-03-01

8.  Association of MICA-TM and MICB C1_2_A microsatellite polymorphisms with tumor progression in patients with colorectal cancer.

Authors:  R Kopp; J Glas; U Lau-Werner; E D Albert; E H Weiss
Journal:  J Clin Immunol       Date:  2009-04-08       Impact factor: 8.317

9.  Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions.

Authors:  Naela A Arreygue-Garcia; Adrian Daneri-Navarro; Alicia del Toro-Arreola; Angel Cid-Arregui; Oscar Gonzalez-Ramella; Luis F Jave-Suarez; Adriana Aguilar-Lemarroy; Rogelio Troyo-Sanroman; Alejandro Bravo-Cuellar; Vidal Delgado-Rizo; Trinidad Garcia-Iglesias; Georgina Hernandez-Flores; Susana Del Toro-Arreola
Journal:  BMC Cancer       Date:  2008-01-21       Impact factor: 4.430

10.  Enhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation.

Authors:  Sisi He; Tao Yin; Dan Li; Xiang Gao; Yang Wan; Xuelei Ma; Tinghong Ye; Fuchun Guo; Jianhong Sun; Ziqiang Lin; Yongsheng Wang
Journal:  J Transl Med       Date:  2013-08-12       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.